Nycrist Pharmatech

PharmaceuticalsSeries AShenzhen, Chinanycrist.com

Latest round

Series A

Last raised

Jan 2018

Total raised

Undisclosed

Investors

1

About Nycrist Pharmatech

Established in 2015 and based in Shenzhen, China, Nycrist Pharmatech Limited is a company that focuses on the research and development of preclinical drugs. The company has a research and development platform and production line of more than 6,000 square meters, including a crystal drug research and development laboratory (CRO), small-scale and pilot laboratories for new drug development, etc. The company's main products include solid preparations, oral film preparations and topical preparations. Its products are used in conditions such as schizophrenia, skin infections and leukemia. The company’s revenue is generated by providing solid preparations, oral film preparations and topical preparations.

Who invested in Nycrist Pharmatech

1 investor across 1 round

See all investors in Nycrist Pharmatech

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jan 10, 2018

    Amount

    Undisclosed

    Investors

    Locked

Questions about Nycrist Pharmatech

Who invested in Nycrist Pharmatech?

Nycrist Pharmatech has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Nycrist Pharmatech raised?

Nycrist Pharmatech has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Nycrist Pharmatech last raise money?

Nycrist Pharmatech's most recent round on record is a Series A, in Jan 2018.

What does Nycrist Pharmatech do?

Established in 2015 and based in Shenzhen, China, Nycrist Pharmatech Limited is a company that focuses on the research and development of preclinical drugs.

Where is Nycrist Pharmatech headquartered?

Nycrist Pharmatech is headquartered in Shenzhen, China.

Which VCs invest in companies like Nycrist Pharmatech?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Nycrist Pharmatech's stage. Their profiles are linked below.

Raising like Nycrist Pharmatech? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.